...
首页> 外文期刊>Microvascular Research: An International Journal >MiR-150 promotes angiogensis and proliferation of endothelial progenitor cells in deep venous thrombosis by targeting SRCIN1
【24h】

MiR-150 promotes angiogensis and proliferation of endothelial progenitor cells in deep venous thrombosis by targeting SRCIN1

机译:MiR-150通过靶向CIN1促进内皮祖细胞内皮祖细胞的血管生成和增殖

获取原文
获取原文并翻译 | 示例

摘要

Venous thromboembolism (VTE), encompassing deep venous thrombosis (DVT) and pulmonary embolism (PE), is the third most common cardiovascular disease. miR-150 is one of important microRNAs which play critical role in various cellular function such as endothelial progenitor cells (EPCs). In this study, we investigate the effect of miR-150 on EPCs function ex vivo and thrombus resolution in vivo. We determined miR-150 expression in EPCs isolated from DVT patients and control subjects by RT-PCR. Potential target of miR-150 was confirmed by bioinformatics analysis and luciferase reporter respectively. The angiogenesis and proliferation were tested by MTT and tube formation assay. A murine model of venous thrombosis was developed as in vivo model. Finally, the effect of miR-150 on EPCs with inferior venous thrombosis were evaluated in vivo. Our data showed that miR-150 was downregulated in EPCs from DVT patients. By using miR-150 agomir and antagomir, we found that miR-150 promoted angiogenesis and proliferation of EPCs. Bioinformatics analysis revealed SRCIN1 as a target of miR-150 and SRCIN1 knockdown inhibited function of EPCs. Forced expression of miR-150 contributed thrombus resolution in a murine model of venous thrombosis. In general, miR-150 was downregulated in EPCs from DVT. Upregulation of miR-150 promoted angiogenesis and proliferation of EPCs by targeting SRCIN1 in vitro and thrombus resolution in vivo.
机译:静脉血栓栓塞(VTE),包括深静脉血栓形成(DVT)和肺栓塞(PE),是第三种最常见的心血管疾病。 miR-150是重要的微小RNA之一,其在各种细胞功能中起关键作用,例如内皮祖细胞(EPC)。在这项研究中,我们研究了MIR-150对体内EPCS功能的影响和血栓分辨率的影响。我们确定了通过RT-PCR与DVT患者分离的EPCS中的miR-150表达。通过生物信息学分析和荧光素酶报告证实了MiR-150的潜在靶标。通过MTT和管形成测定测试血管生成和增殖。静脉血栓形成的小鼠模型是如体内模型开发的。最后,在体内评估MIR-150对具有较差静脉血栓形成的EPC的影响。我们的数据显示MIR-150在DVT患者的EPC中下调。通过使用MiR-150 Agomir和Antagomir,发现MiR-150促进了EPCS的血管生成和增殖。生物信息学分析显示SRCIN1作为MIR-150的靶标和SRCIN1敲低抑制EPC的功能。 miR-150的强迫表达在静脉血栓形成的小鼠模型中贡献了血栓分辨率。通常,MiR-150在DVT的EPC中下调。通过在体内靶向Srcin1和血栓分辨率促进MiR-150的U-150促进EPC的血管生成和增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号